Delivery Order SPE2DB22D6029-SPE2DB25FLVPH
- Not listed
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of the drug Jevtana 60 mg/1.5 ml kit, with a potential value of $14,737.98 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver this pharmaceutical product to DLA Troop Support Medical facilities...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $7,169.46 to supply JEVTANA 60 MG/1.5 ML KIT 1.5ML pharmaceutical products. Performance will take place at Amerisourcebergen's Conshohocken, Pennsylvania facility, with completion by December 29, 2023. The delivery order was awarded against an indefinite delivery contract held by Amerisourcebergen's Corporate Office division to provide pharmaceuticals and medical...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JEVTANA 60 MG/1.5 ML KIT 1.5ML, a specialty cancer medication. The delivery order, valued at $22,106.97, has a firm fixed-price contract type and is not set-aside. It is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999, that enables the government to...
- This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order for the pharmaceutical product JEVTANA 60 MG/1.5 ML KIT 1.5ML, with a potential value of $7,368.99 and a completion date of March 25, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC)...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $14,338.92 to supply JEVTANA 60 MG/1.5 ML KIT 1.5ML pharmaceutical products. Performance will take place at Amerisourcebergen's Conshohocken, Pennsylvania facility, with completion by January 8, 2024. Issued against an indefinite delivery contract held by Amerisourcebergen with no set-aside designation, this award continues the company's support of DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $14,737.98 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide JEVTANA 60 MG/1.5 ML KIT 1.5ML pharmaceutical products. This order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of DLA Troop Support Medical programs. The delivery order has a completion date of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JEVTANA 60 MG/1.5 ML KIT 1.5ML, a medical product, with a ceiling value of $30,006.73 and a completion date of December 1, 2022. The contract is a Firm Fixed Price (FFP) delivery order, and is not set aside for any specific business category. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency Troop Support Medical awarded a $14,338.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 60 milligram/1.5 milliliter kits of JEVTANA, an injectable medication used to treat prostate cancer. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three week period concluding on August 28, 2023. The delivery order was issued under the Medical-Surgical Prime Vendor contract, a multiple...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $30,494.68 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of the specialty drug JEVTANA 60 MG/1.5 ML KIT 1.5ML, with a period of performance through December 5, 2024. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop Support Medical, which serves as a comprehensive vehicle for...
- The Defense Logistics Agency awarded a $1,131.88 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Jatenzo 158 mg capsules (120-count unit). This firm fixed-price delivery order, which is a child contract under a larger vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. The award utilized no set-aside designation and was competitively awarded through open...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVPHDelivery Order
The Defense Logistics Agency awarded a $16,377.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jevtana (cabazitaxel) 60 mg/1.5 ml kits. This is a non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. Jevtana is a chemotherapy agent used in the treatment of certain cancers, reflecting DLA's ongoing procurement of specialty pharmaceutical products for military healthcare systems. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying a comprehensive range of brand-name and generic medications, vaccines, and medical devices to military and veteran healthcare systems. The company's role under the SPE2DX contract vehicle enables it to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities globally. This delivery order represents a routine transaction within AmerisourceBergen's extensive portfolio of competitively awarded federal pharmaceutical supply contracts, demonstrating the company's capability to fulfill specialized medical supply requirements across multiple therapeutic domains for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.4k | 7/22/25 |